Panthera Biopartners

What Panthera Biopartners does

Panthera Biopartners is a UK-based Site Management Organization (SMO) founded in 2019 and headquartered in Preston, England. The company operates a network of seven dedicated clinical trial sites across the UK — Glasgow, Enfield, Preston, Rochdale, Sheffield, York, and Keele — providing site management, patient recruitment, trial execution, and protocol delivery services to pharmaceutical sponsors and contract research organizations. In April 2026, Panthera extended its footprint into continental Europe through the acquisition of Hungary's leading clinical research organization, OEC (Óbuda Health Center).

The company's core offering is dedicated clinical trial site operations, with an operational model that materially outperforms the UK NHS comparator: Panthera activates sites in approximately 50 days versus the NHS's 150-day target (4.5 months versus 8 months overall), reducing sponsor timelines and per-trial costs. Active trials span cardiovascular, metabolic (cholesterol, fatty liver disease), infectious disease (C. difficile, pandemic flu), musculoskeletal (knee pain and weight management), neurological (menstrual migraine), and behavioural (alcohol consumption) therapeutic areas. Named enterprise customers include Eli Lilly, Roche, Pfizer, and Parexel (via the Parexel Site Alliance).

Panthera generates revenue through contracted site services for pharmaceutical sponsors and CROs (clinical trial participation is free for patient volunteers). The company is privately held, backed by private equity firm LDC alongside earlier investors BGF and Gresham House Ventures who together contributed £10 million in April 2022. The company employs 51–100 staff, operates a consumer-facing recruitment website (Panthera Clinic), and is a member of the Association of Multisite Research Corporations and the NIHR Research Delivery Network ecosystem.

Name

Panthera Biopartners

Legal name

Panthera BioPartners Limited

Website

https://panthera-bio.com/

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

51–100 employees

Short description

Panthera Biopartners is a UK-based Site Management Organization operating seven dedicated clinical trial sites and, since April 2026, Hungary's OEC CRO, providing site management, patient recruitment, and trial execution services to pharmaceutical sponsors including Eli Lilly, Roche, Pfizer, and Parexel.

Ownership category

akta.pro rank

Product category

Clinical Trial Site Management Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Site Identification & Feasibility (HLAGACAB), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial site management
• Site management organization
• Patient recruitment services
• Clinical research services
• Dedicated clinical trial sites

Headquarters

HQ city

Preston

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Site Services: Panthera generates revenue by operating dedicated clinical trial sites for pharmaceutical companies and CROs. The company conducts trials across multiple therapeutic areas, providing site management, patient recruitment, and trial execution services to sponsors.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Panthera Biopartners operates a network of dedicated clinical trial sites across the UK and Western Europe as a Site Management Organization (SMO). The company recruits patient volunteers and runs clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs), providing site management, patient enrollment, and trial execution services. Panthera conducts trials across multiple therapeutic areas including cardiovascular, cholesterol, fatty liver disease, knee pain, menstrual migraines, C. diff, and alcohol consumption.

Product overview

Panthera Biopartners is a UK-based Site Management Organization (SMO) operating the Panthera Clinic brand, which provides a network of dedicated clinical trial sites across the UK and Western Europe. The core offering consists of clinical trial site management services, including patient recruitment, enrollment, and site activation. The company operates seven clinic locations (Glasgow, Enfield, Preston, Rochdale, Sheffield, York, Keele) and conducts trials across multiple therapeutic areas including cardiovascular, metabolic disorders, infectious diseases, and neurological conditions. Panthera's SMO model delivers faster trial start-up (approximately 50 days vs 150-day NHS target) and works with major pharmaceutical companies including Eli Lilly, Roche, and Pfizer. The portfolio includes multiple named clinical trial programs, and the company has expanded into Europe through the April 2026 acquisition of Hungary's OEC Clinical Research.

Differentiator

Problem solved

Functional benefit

Products and services

• Panthera Clinic (Dedicated Clinical Trial Site Network) UK-based network of dedicated clinical trial sites offering paid clinical trials across multiple therapeutic areas. Operates seven clinic locations (Glasgow, Enfield, Preston, Rochdale, Sheffield, York, Keele) providing patient recruitment, trial management, and enrollment services for pharmaceutical sponsors and CROs.
• Clinical Trial Site Network (SMO Services) An established SMO (Site Management Organization) model delivering dedicated clinical trial sites across the UK and Western Europe, managing trials in specialist medical fields for pharmaceutical companies including Eli Lilly, Roche, and Pfizer.
• Pandemic Flu Clinical Trial Clinical trial investigating pandemic flu treatments and prevention methods, conducted at Panthera Clinic sites for eligible patient volunteers.
• High / Bad Cholesterol Clinical Trial Clinical trial evaluating treatments for high or bad cholesterol levels, conducted for eligible patient volunteers.
• Knee Pain and Weight Management Clinical Trial Clinical trial investigating interventions for knee pain combined with weight management, recruiting eligible patient volunteers.
• Alcohol Consumption Clinical Trials Clinical trials exploring new ways to address alcohol consumption-related health issues, recruiting eligible patient volunteers.
• C. diff Clinical Trials Clinical trials researching prevention methods for C. difficile infection, recruiting eligible patient volunteers.
• Menstrual Migraine Clinical Trials Clinical trials focused on treatments for menstrual migraines, recruiting eligible patient volunteers.
• Cardiovascular Clinical Trials Clinical trials exploring new treatments for heart health and cardiovascular conditions, recruiting eligible patient volunteers.
• Fatty Liver Disease Clinical Trials Clinical trials investigating treatments for fatty liver disease, recruiting eligible patient volunteers.
• OEC Clinical Research (Hungary) Hungary's leading clinical research organisation, acquired by Panthera Biopartners in April 2026 to deliver clinical research services in continental Europe as part of the Panthera network.

Quantifiable outcome

• Reduces trial setup time by over 3 months compared to NHS public sector
• +3 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• Association of Multisite Research Corporations (AMRC)coreStrategic or Co-development Partner · 17 March 2026Panthera Biopartners joined AMRC, a trade organization for clinical research organizations, to enhance collaboration, advocacy, and contribution to high-quality, scalable clinical trials worldwide.
• NimbuscareminorStrategic or Co-development PartnerNimbuscare is listed as a trusted partner/organization working with Panthera Clinic.
• NIHR Research Delivery NetworkcoreStrategic or Co-development PartnerNational Institute for Health and Care Research (NIHR) Research Delivery Network is listed as a trusted partner supporting Panthera's clinical research operations.
• Affinity CareminorStrategic or Co-development PartnerAffinity Care is listed as a trusted partner/organization working with Panthera Clinic.
• Parexel (Site Alliance)coreStrategic or Co-development PartnerParexel Site Alliance partner - Panthera operates as an alliance site for Parexel, a major CRO, providing clinical trial site services.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Parexel: Global CRO running site alliances (Panthera is a Parexel Site Alliance partner); comparable as a sponsor-facing clinical research services provider, though at much larger scale.
• Celerion: Clinical research organisation specialising in early-phase trials with dedicated site operations, comparable in therapeutic focus and sponsor relationships.
• Simbec-Orion: UK-based CRO with dedicated clinical trial site operations serving pharma sponsors, comparable in therapeutic breadth and geographic base.
• Richmond Pharmacology: UK-based clinical research organisation operating dedicated early-phase trial sites, directly comparable to Panthera's SMO model in the British market.
• Worldwide Clinical Trials: Mid-sized global CRO offering clinical trial site management and patient recruitment services comparable to Panthera's core offering, serving similar pharma customers.
• Quotient Sciences: UK-headquartered clinical research organisation providing drug development and site services to pharma, overlapping in target customers and trial delivery model.
• Hammersmith Medicines Research: UK-based SMO running dedicated clinical trial sites with direct patient recruitment, comparable in size, geography, and operating model to Panthera.

Broad incumbents

• Medpace: Mid-to-large CRO with full-service clinical trial capabilities serving biotech and pharma; relevant comparable for sponsor relationships though broader in scope.
• ICON plc: Major global CRO providing clinical trial services to pharma; competes for the same sponsor relationships but as part of a much broader services portfolio.
• IQVIA: Largest global CRO with extensive site network and biotech/pharma services portfolio; comparable sponsor base but vastly broader scope than Panthera's niche SMO focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Panthera Biopartners